Free online reference management for clinicians and scientists
Recent "dmd" articles
- These articles and links have been posted by Connotea users using the tag "dmd".
- To add to this collection, or to start your own library:
Watch a short video (2m 41s)
Create a Connotea Community Page about this tag. 

Number of articles per page:
BMC Genomics 9 (1), 494 (20 Oct 2008)
Mol Ther 17 (5), 864-71 (10 Mar 2009)
Vivo-Morpholinos for exon skipping in mice
Annals of neurology, (13 Mar 2009)
Exon-skipping induced by Morpholinos causes systemic expression of functional dystrophin in a DMD dog model.
Molecules (Basel, Switzerland) 14 (3), 1304-23 (2009)
Review of some recent in vivo work with delivery-enabled Morpholino oligos. Open-access.
Cell transplantation 16 (6), 563-77 (2007)
www.plosone.org
Archives of neurology 66 (1), 32-8 (Jan 2009)
Yokota T, Takeda S, Lu QL, Partridge TA, Nakamura A, Hoffman EP. A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground. Arch Neurol. 2009 Jan;66(1):32-8.
The journal of gene medicine, (12 Jan 2009)
Heemskerk HA, de Winter CL, de Kimpe SJ, van Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. J Gene Med. 2009 Jan 12. [Epub ahead of print]
Proteomics, (08 Jan 2009)
Doran P, Wilton SD, Fletcher S, Ohlendieck K. Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics. 2009 Jan 8. [Epub ahead of print]
Oligonucleotides
Bauman J, Jearawiriyapaisarn N, Kole R. Therapeutic Potential of Splice-Switching Oligonucleotides. Oligonucleotides. 2009 Jan 6. [Epub ahead of print]
<< Prev 0 Showing entries 1 to 10 of 24 total Next 10 >>


